Patient assistance
Free help paying for autoimmune and skin medications.
mendmeds tracks 29 autoimmune and skin medications, with 59 active assistance programs, each linked to its official source with the date we checked it.
Browse
Every autoimmune and skin medication we cover
- Abrilada (adalimumab-afzb)Medicare options1 active program
- Actemra (tocilizumab)2 active programsTypically around $4,500 per month without assistance
- Amjevita (adalimumab-atto)2 active programs
- Avtozma (tocilizumab-anoh)2 active programs
- Cosentyx (secukinumab)Medicare options3 active programsTypically around $6,200 per month without assistance
- Cyltezo (adalimumab-adbm)2 active programs
- Dupixent (dupilumab)Medicare options2 active programsTypically around $3,500 per month without assistance
- Enbrel (etanercept)2 active programsTypically around $7,000 per month without assistance
- Hadlima (adalimumab-bwwd)2 active programs
- Humira (adalimumab)Medicare options2 active programsTypically around $7,000 per month without assistance
- Hyrimoz (adalimumab-adaz)Medicare options2 active programs
- Olumiant (baricitinib)Medicare options2 active programsTypically around $2,800 per month without assistance
- Opzelura (ruxolitinib)Medicare options2 active programs
- Orencia (abatacept)Medicare options2 active programsTypically around $5,200 per month without assistance
- Otezla (apremilast)Medicare options2 active programsTypically around $4,000 per month without assistance
- Pyzchiva (ustekinumab-ttwe)1 active program
- Rinvoq (upadacitinib)Medicare options2 active programsTypically around $6,000 per month without assistance
- Selarsdi (ustekinumab-aekn)1 active program
- Skyrizi (risankizumab-rzaa)Medicare options2 active programs
- Stelara (ustekinumab)2 active programs
- Steqeyma (ustekinumab-stba)2 active programs
- Taltz (ixekizumab)Medicare options2 active programsTypically around $6,200 per month without assistance
- Tofidence (tocilizumab-bavi)2 active programs
- Tremfya (guselkumab)Medicare options2 active programs
- Tyenne (tocilizumab-aazg)2 active programs
- Wezlana (ustekinumab-auub)2 active programs
- Xeljanz (tofacitinib)Medicare options2 active programsTypically around $5,800 per month without assistance
- Yesintek (ustekinumab-kfce)5 active programs
- Yusimry (adalimumab-aqvh)2 active programsTypically around $995 per month without assistance